FRACTION - protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)

Isfort, Susanne ; Bubnoff, Nikolas von ; Al-Ali, Haifa Kathrin ; Becker, Heiko ; Götze, Thorsten ; Le Coutre, Philipp ; Griesshammer, Martin ; Moskwa, Claudia ; Wohn, Luisa ; Riedel, Johanna